Contrast‐enhanced MR imaging of diffuse and focal splenic disease with use of magnetic starch microspheres

Burkhard P. Kreft, Akihiro Tanimoto, Susan Leffler, J. Paul Finn, Audun N. Øksendal, David D. Stark

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The diagnostic value of magnetic starch microspheres (MSM), a new superparamagnetic contrast agent, was studied in experimental models of diffuse and focal splenic disease in rats by means of ex vivo relaxometry and in vivo magnetic resonance (MR) imaging. Owing to small differences in unenhanced T1 and T2 values between diffuse lymphoma and normal spleen, MR imaging failed to distinguish tumor‐bearing animals from control animals by signal‐to‐noise ratios (SNRs) obtained with T1‐ and T2‐weighted spin‐echo sequences. One hour after injection of 20 μmol/kg MSM, lymphomatous spleen showed significantly (P <.001) reduced enhancement relative to normal splenic tissue. As a result, animals with diffuse lymphoma (SNR: 10.3 ± 1.7) could be easily differentiated from control animals (SNR: 5.5 ± 0.6) on T2‐weighted (TR msec/TE msec = 2,000/45) images. In focal splenic disease, MSM produced normal enhancement of nontumorous splenic tissue, whereas relaxation times of tumors were not different before and after contrast agent injection. On T2‐weighted images (2,000/45), the tumor‐spleen contrast‐to‐noise ratio increased from (4.8 ± 1.6 to 21.8 ± 1.9 +354%), improving conspicuity of splenic tumors. The results show that MSM‐enhanced MR imaging improves the detection of diffuse and focal splenic disease.

Original languageEnglish
Pages (from-to)373-379
Number of pages7
JournalJournal of Magnetic Resonance Imaging
Volume4
Issue number3
DOIs
Publication statusPublished - 1994

Fingerprint

Splenic Diseases
Microspheres
Starch
Magnetic Resonance Imaging
Non-Hodgkin's Lymphoma
Contrast Media
Spleen
Injections
Neoplasms
Theoretical Models

Keywords

  • Contrast enhancement
  • Contrast media
  • Contrast media, experimental studies
  • Iron
  • Relaxometry
  • Spleen, MR, 775.12143
  • Spleen, neoplasms, 775.12143

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Contrast‐enhanced MR imaging of diffuse and focal splenic disease with use of magnetic starch microspheres. / Kreft, Burkhard P.; Tanimoto, Akihiro; Leffler, Susan; Finn, J. Paul; Øksendal, Audun N.; Stark, David D.

In: Journal of Magnetic Resonance Imaging, Vol. 4, No. 3, 1994, p. 373-379.

Research output: Contribution to journalArticle

Kreft, Burkhard P. ; Tanimoto, Akihiro ; Leffler, Susan ; Finn, J. Paul ; Øksendal, Audun N. ; Stark, David D. / Contrast‐enhanced MR imaging of diffuse and focal splenic disease with use of magnetic starch microspheres. In: Journal of Magnetic Resonance Imaging. 1994 ; Vol. 4, No. 3. pp. 373-379.
@article{e254c40f433e4ce995dbe819f31dccb1,
title = "Contrast‐enhanced MR imaging of diffuse and focal splenic disease with use of magnetic starch microspheres",
abstract = "The diagnostic value of magnetic starch microspheres (MSM), a new superparamagnetic contrast agent, was studied in experimental models of diffuse and focal splenic disease in rats by means of ex vivo relaxometry and in vivo magnetic resonance (MR) imaging. Owing to small differences in unenhanced T1 and T2 values between diffuse lymphoma and normal spleen, MR imaging failed to distinguish tumor‐bearing animals from control animals by signal‐to‐noise ratios (SNRs) obtained with T1‐ and T2‐weighted spin‐echo sequences. One hour after injection of 20 μmol/kg MSM, lymphomatous spleen showed significantly (P <.001) reduced enhancement relative to normal splenic tissue. As a result, animals with diffuse lymphoma (SNR: 10.3 ± 1.7) could be easily differentiated from control animals (SNR: 5.5 ± 0.6) on T2‐weighted (TR msec/TE msec = 2,000/45) images. In focal splenic disease, MSM produced normal enhancement of nontumorous splenic tissue, whereas relaxation times of tumors were not different before and after contrast agent injection. On T2‐weighted images (2,000/45), the tumor‐spleen contrast‐to‐noise ratio increased from (4.8 ± 1.6 to 21.8 ± 1.9 +354{\%}), improving conspicuity of splenic tumors. The results show that MSM‐enhanced MR imaging improves the detection of diffuse and focal splenic disease.",
keywords = "Contrast enhancement, Contrast media, Contrast media, experimental studies, Iron, Relaxometry, Spleen, MR, 775.12143, Spleen, neoplasms, 775.12143",
author = "Kreft, {Burkhard P.} and Akihiro Tanimoto and Susan Leffler and Finn, {J. Paul} and {\O}ksendal, {Audun N.} and Stark, {David D.}",
year = "1994",
doi = "10.1002/jmri.1880040324",
language = "English",
volume = "4",
pages = "373--379",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Contrast‐enhanced MR imaging of diffuse and focal splenic disease with use of magnetic starch microspheres

AU - Kreft, Burkhard P.

AU - Tanimoto, Akihiro

AU - Leffler, Susan

AU - Finn, J. Paul

AU - Øksendal, Audun N.

AU - Stark, David D.

PY - 1994

Y1 - 1994

N2 - The diagnostic value of magnetic starch microspheres (MSM), a new superparamagnetic contrast agent, was studied in experimental models of diffuse and focal splenic disease in rats by means of ex vivo relaxometry and in vivo magnetic resonance (MR) imaging. Owing to small differences in unenhanced T1 and T2 values between diffuse lymphoma and normal spleen, MR imaging failed to distinguish tumor‐bearing animals from control animals by signal‐to‐noise ratios (SNRs) obtained with T1‐ and T2‐weighted spin‐echo sequences. One hour after injection of 20 μmol/kg MSM, lymphomatous spleen showed significantly (P <.001) reduced enhancement relative to normal splenic tissue. As a result, animals with diffuse lymphoma (SNR: 10.3 ± 1.7) could be easily differentiated from control animals (SNR: 5.5 ± 0.6) on T2‐weighted (TR msec/TE msec = 2,000/45) images. In focal splenic disease, MSM produced normal enhancement of nontumorous splenic tissue, whereas relaxation times of tumors were not different before and after contrast agent injection. On T2‐weighted images (2,000/45), the tumor‐spleen contrast‐to‐noise ratio increased from (4.8 ± 1.6 to 21.8 ± 1.9 +354%), improving conspicuity of splenic tumors. The results show that MSM‐enhanced MR imaging improves the detection of diffuse and focal splenic disease.

AB - The diagnostic value of magnetic starch microspheres (MSM), a new superparamagnetic contrast agent, was studied in experimental models of diffuse and focal splenic disease in rats by means of ex vivo relaxometry and in vivo magnetic resonance (MR) imaging. Owing to small differences in unenhanced T1 and T2 values between diffuse lymphoma and normal spleen, MR imaging failed to distinguish tumor‐bearing animals from control animals by signal‐to‐noise ratios (SNRs) obtained with T1‐ and T2‐weighted spin‐echo sequences. One hour after injection of 20 μmol/kg MSM, lymphomatous spleen showed significantly (P <.001) reduced enhancement relative to normal splenic tissue. As a result, animals with diffuse lymphoma (SNR: 10.3 ± 1.7) could be easily differentiated from control animals (SNR: 5.5 ± 0.6) on T2‐weighted (TR msec/TE msec = 2,000/45) images. In focal splenic disease, MSM produced normal enhancement of nontumorous splenic tissue, whereas relaxation times of tumors were not different before and after contrast agent injection. On T2‐weighted images (2,000/45), the tumor‐spleen contrast‐to‐noise ratio increased from (4.8 ± 1.6 to 21.8 ± 1.9 +354%), improving conspicuity of splenic tumors. The results show that MSM‐enhanced MR imaging improves the detection of diffuse and focal splenic disease.

KW - Contrast enhancement

KW - Contrast media

KW - Contrast media, experimental studies

KW - Iron

KW - Relaxometry

KW - Spleen, MR, 775.12143

KW - Spleen, neoplasms, 775.12143

UR - http://www.scopus.com/inward/record.url?scp=0028432673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028432673&partnerID=8YFLogxK

U2 - 10.1002/jmri.1880040324

DO - 10.1002/jmri.1880040324

M3 - Article

C2 - 8061436

AN - SCOPUS:0028432673

VL - 4

SP - 373

EP - 379

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 3

ER -